Researchers based in the West Midlands have been funded to study the affects of weight-loss injections on patients with ...

BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has successfully completed production of its largest ...

The European Commission says the war in Iran has added a 24 billion euros to the EU's collective fuel import bills in its ...

BNB Plus Corp. ("BNB Plus" or the "Company"), today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has successfully completed production of its largest order in LineaRx ...

When GLP-1s are offered without expert clinical and lifestyle support, they lose effectiveness and lead to wasted money.

Anhedonia, the clinical term for “Ozempic personality," is described by those who experience it as a general flattening of ...

The Centers for Medicare & Medicaid Services announced in a memo April 21that it is delaying implementation of the Medicare Part D portion of the Better Approaches to Lifestyle and Nutrition for ...

Ways to support our beautiful but fragile planet, why police still struggle to end shootings during mental health calls, and ...

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

The Trump administration had planned for insurers to provide cheap weight loss drugs to seniors through a Medicare pilot ...

Novo Nordisk is losing GLP-1 and diabetes market share in key regions as Eli Lilly's Zepbound and Mounjaro gain U.S.

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?